Evaluation of metabolic parameters and cardiac function is important to determine the decrease in aerobic exercise capacity under hypoxic conditions. However, the variations in metabolic parameters and cardiac function and the reasons for the decrease in aerobic exercise capacity under hypoxic conditions have not been clearly explained. The purpose of this study was to compare the responses between sea level and various acute normobaric hypoxic conditions on metabolic parameters and cardiac function during exercise and recovery in order to evaluate aerobic exercise capacity. Ten healthy male participants (21.3 ± 3.06 y) performed submaximal bicycle exercise (116.7 ± 20.1 W and 60 rpm) at sea level (20.9 % O2) and under various normobaric hypoxic conditions (16.5 % O2, 14.5 % O2, 12.8 % O2, and 11.2 % O2) in a random order. Metabolic parameters (arterial oxygen saturation; SPO2, oxygen consumption; VO2, blood lactate level) and cardiac function (heart rate; HR, stroke volume; SV, end-systolic volume; ESV, end-diastolic volume; EDV, ejection fraction; EF, cardiac output; CO) were measured at rest, during exercise (30 min), and recovery (30 min). We compared the responses on metabolic parameters and cardiac function between the different oxygen partial pressure conditions during exercise and recovery. The various acute normobaric hypoxic conditions did not affect VO2 and SV during exercise and recovery. SPO2 decreased (p < .05) and blood lactate level increased (p < .05) as the oxygen partial pressure decreased. HR, EF, CO increased (p < .05) and EDV, ESV decreased (p < .05) at oxygen partial pressures of 14.5 % O2 and below compared with 20.9 and 16.5 % O2 during exercise and recovery. A decrease in the oxygen partial pressure to 14.5 % O2 and below might be associated with significant changes in metabolic parameters and cardiac function during exercise and recovery. These changes are an acute compensation response to reduced aerobic exercise capacity by decreased oxygen delivering and utilizing capacities under hypoxic conditions.

Background: While people’s living standards are improving, the incidence of chronic diseases due to a lack of exercise is increasing. Complex health conditions (e.g., metabolic syndrome) are becoming common, and means to lower their incidence are essential. Methods: This study systematically reviewed the literature and performed a meta-analysis on the effects of Baduanjin exercise on metabolic syndrome-related factors. Using four English databases and three Chinese databases, randomized controlled trials on the effects of Baduanjin exercise on metabolic syndrome were identified. We analyzed whether Baduanjin could alleviate various metabolic syndrome indicators according to our selection guidelines. Results: We found that Baduanjin exercise had positive effects on blood pressure (systolic blood pressure: mean difference (MD)=-6.39; 95% confidence interval (CI): -9.86 to -2.92; I2=12%; diastolic blood pressure: MD=-2.86; 95% CI: -5.96 to -0.23; I2=35%; P=0.07) and total cholesterol (standardized mean (SMD)=-0.55; 95% CI: -1.11 to 0.02; I2=86%; P=0.06), triglyceride (SMD=-0.29; 95% CI: -1.13 to - 0.56; I2=94%; P<0.51), and low-density cholesterol (SMD =-0.33; 95% CI: -0.52 to -0.14; I2=0%; P<0.0007) levels. Conclusion: This evidence shows that Baduanjin exercise provides beneficial effects by improving metabolic syndrome and cardiovascular disease in adults. This suggests that Baduanjin exercise could be an effective alternative or complementary approach to conventional treatments for adults with metabolic problems. Additionally, these findings suggest that more rigorous randomized control trials are needed in the future.

Background/Objectives: Impaired angiogenesis and vascular dysfunction are central features of chronic diseases such as cardiovascular disorders, neurodegeneration, and metabolic syndrome. Vascular endothelial growth factor (VEGF) plays a pivotal role in vascular repair and metabolic regulation, yet its responses to exercise remain inconsistently reported. This study aimed to systematically compare the effects of different exercise modalities and doses on VEGF levels across diverse populations. Methods: This review was registered in PROSPERO (CRD42025643709) and followed PRISMA guidelines. PubMed, Web of Science, Embase, and Cochrane Library were searched until 16 January 2025. Eligible studies were randomized or quasi-experimental trials reporting exercise-induced changes in serum/plasma VEGF. Data were extracted and assessed independently using JBI tools. Exercise types were categorized and doses standardized as metabolic equivalents (METs). Network meta-analysis was performed in Stata17.0 (SMD as effect size), with SUCRA used for ranking. Dose–response relationships were examined by meta-regression (remr package), and publication bias was assessed via funnel plots. Results: Twenty-eight studies (N = 1138) were included. In healthy adults, lower-limb resistance training produced the greatest VEGF increase, with benefits observed above ~600 METs-min/week and peaking near 1950 METs-min/week. Among obese individuals, combined aerobic and resistance training under hypoxic conditions showed the highest VEGF response, though dose-specific effects were not significant. In patients with chronic conditions, upper-limb resistance training within 756–950 METs-min/week was most effective, displaying a U-shaped dose–response relationship. No substantial publication bias was detected. Conclusions: The VEGF response to exercise appears to be influenced by both population characteristics and training dosage. High-intensity lower-limb resistance training may provide greater benefits for healthy adults, while obese individuals might experience enhanced responses with combined training under hypoxic conditions. For clinical populations, moderate-dose upper-limb resistance training may be particularly beneficial. Large-scale, long-term trials are needed to further clarify and refine exercise prescriptions targeting VEGF-mediated vascular adaptations.

This study examines whether health-related quality of life (HRQoL) scores differ due to the frequency of walking or physical activity (PA) throughout a week in diabetic patients in Korea. This population-based cross-sectional study used data from the 2018–2021 Korea National Health and Nutrition Examination Survey. The dependent variable was HRQoL scores as measured with EuroQol-5D (EQ-5D). The independent variables were defined as three types of PA: (1) walking; (2) moderate; and (3) vigorous. An estimated population size of 2,376,066 was included in this study. The mean (95% confidence interval (CI)) age of patients was 60.12 years (59.23, 60.81), and 53.0% were female. The mean (95% CI) of EQ-5D was 0.867 (0.857, 0.877). The majority of diabetic patients reported walking daily (39.05%, 95% CI; 36.28–41.81%), while a significant proportion did not engage in moderate (65.45%, 95% CI; 62.79–68.11%) or vigorous (78.38%, 95% CI; 73.02–77.73%) PA at all. After controlling for covariates, EQ-5D scores significantly increased when patients had walked once per week for at least 10 min in the Tobit regression model. The frequency of walking was the most significant predicting factor for better HRQoL in patients with type 2 diabetes.